Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Sutherland

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Molecular Modeling|August 24, 2004
Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutationsJeffrey J Sutherland, Lee A O'Brien, David Lillicrap, et al.
Journal of Chemical Information and Modeling|October 25, 2007
Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracyJeffrey J Sutherland, Ravi K Nandigam, Jon A Erickson, et al.
Drug Discovery Today|June 23, 2005
Kinomics: characterizing the therapeutically validated kinase spaceMichal Vieth, Jeffrey J Sutherland, Daniel H Robertson, et al.
Plos Computational Biology|March 31, 2016
Assessing Concordance of Drug-Induced Transcriptional Response in Rodent Liver and Cultured HepatocytesJeffrey J Sutherland, Robert A Jolly, Keith M Goldstein, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 1, 2020
A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-term AssaysJ Christopher Corton, Thomas Hill, Jeffrey J Sutherland, et al.
Journal of Chemical Information and Modeling|December 5, 2008
Predicting the accuracy of ligand overlay methods with Random Forest modelsRavi K Nandigam, David A Evans, Jon A Erickson, et al.
Molecular Cancer Therapeutics|January 11, 2011
A robust high-content imaging approach for probing the mechanism of action and phenotypic outcomes of cell-cycle modulatorsJeffrey J Sutherland, Jonathan Low, Wayne Blosser, et al.
ACS Chemical Neuroscience|June 23, 2017
Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug MonitoringJeffrey J Sutherland, Ryan D Morrison, J Scott Daniels, et al.
Journal of Medicinal Chemistry|June 22, 2012
Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomesJeffrey J Sutherland, John W Raymond, James L Stevens, et al.
Plos One|March 5, 2015
Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactionsJeffrey J Sutherland, Thomas M Daly, Xiong Liu, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Molecular Modeling|August 24, 2004
Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutationsJeffrey J Sutherland, Lee A O'Brien, David Lillicrap, et al.
Journal of Chemical Information and Modeling|October 25, 2007
Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracyJeffrey J Sutherland, Ravi K Nandigam, Jon A Erickson, et al.
Drug Discovery Today|June 23, 2005
Kinomics: characterizing the therapeutically validated kinase spaceMichal Vieth, Jeffrey J Sutherland, Daniel H Robertson, et al.
Plos Computational Biology|March 31, 2016
Assessing Concordance of Drug-Induced Transcriptional Response in Rodent Liver and Cultured HepatocytesJeffrey J Sutherland, Robert A Jolly, Keith M Goldstein, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 1, 2020
A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-term AssaysJ Christopher Corton, Thomas Hill, Jeffrey J Sutherland, et al.
Journal of Chemical Information and Modeling|December 5, 2008
Predicting the accuracy of ligand overlay methods with Random Forest modelsRavi K Nandigam, David A Evans, Jon A Erickson, et al.
Molecular Cancer Therapeutics|January 11, 2011
A robust high-content imaging approach for probing the mechanism of action and phenotypic outcomes of cell-cycle modulatorsJeffrey J Sutherland, Jonathan Low, Wayne Blosser, et al.
ACS Chemical Neuroscience|June 23, 2017
Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug MonitoringJeffrey J Sutherland, Ryan D Morrison, J Scott Daniels, et al.
Journal of Medicinal Chemistry|June 22, 2012
Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomesJeffrey J Sutherland, John W Raymond, James L Stevens, et al.
Plos One|March 5, 2015
Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactionsJeffrey J Sutherland, Thomas M Daly, Xiong Liu, et al.
Pageof 4